Announcements Trials

Browse Landscape

Phase

Phase 2 18 Phase 3 4 Phase 1/2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 26 OTHER 25 NIH 5 NETWORK 4 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Bevacizumab 4 Zoledronic Acid 3 Cisplatin 3 Capecitabine 3 spartalizumab 2 anlotinib 2 Radiotherapy 2 Positron Emission Tomography Computed Tomography 2 Metformin 2 Letrozole 2 Drug Therapy 2 vosaroxin 1 venetoclax 1 tislelizumab 1 pembrolizumab 1 enzalutamide 1 empagliflozin 1 atezolizumab 1 apatinib 1 abiraterone 1 XELOX 1 Vacuum Curettage 1 Tyrosine Kinase Inhibitors 1 Tuberculin 1 Sorafenib 1 Sodium Chloride 1 S 1 (combination) 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER_GOV × Paclitaxel × Clear all

NCT02741856 2018-10-25

SCOPE2

Velindre NHS Trust

Phase 2/3 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡